Zimmer Biomet Holdings Inc

NYSE: ZBH    
Share price (5/16/24): $121.23    
Market cap (5/16/24): $24.9 billion
5 Zimmer Biomet Holdings Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.1
from 8-K 13 pages Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan
12/34/56
EX-10.54
from 10-K 31 pages Change in Control Severance Agreement
12/34/56
EX-10.53
from 10-K 5 pages Deed of Amendment
12/34/56
EX-10.52
from 10-K 4 pages Recitals (A) on 5 May 2021, Zimmer Gmbh ("Employer" or "Company" as Case May Be) and Wilfred Van Zuilen ("Executive"; the Employer and the Executive Each Individually, a "Party" and Together, the "Parties") Have Entered Into a Change in Control Severance Agreement ("Cic Agreement"). (B) the Parties Know Wish to Amend the Cic Agreement
12/34/56
EX-10.51
from 10-K 5 pages Amendment to Change in Control Severance Agreement
12/34/56
EX-10.6
from 10-Q 5 pages Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors
12/34/56
EX-10.3
from 8-K 11 pages Chief Executive Officer Confidentiality, Non-Competition and Non-Solicitation Agreement
12/34/56
EX-10.2
from 8-K 26 pages Change in Control Severance Agreement
12/34/56
EX-10.1
from 8-K 4 pages Confidential August 21, 2023 Ivan Tornos Dear Ivan, We Are Pleased to Offer You the Role of President and Chief Executive Officer (CEO) of Zimmer Biomet Holdings, Inc. (The Company or Zimmer Biomet). You Will Report Directly to the Company’s Board of Directors. Your Salary Grade Will Be Level Z01. Your Start Date as President and CEO Will Be Tuesday, August 22, 2023 (The “Effective Date”), at Which Time You Will No Longer Serve as the Company’s Chief Operating Officer. Initial Base Salary in This Role, Beginning on the Effective Date, Your Initial Annualized Salary Will Be One Million Two Hundred Thousand Dollars ($1,200,000). Annual Merit Adjustment Zimmer Biomet’s Annual Merit Review Process Involves Base Pay Adjustments Consistent With Job Performance. Merit Adjustment Are Based on Performance During the Calendar Year. Executive Performance Incentive Plan
12/34/56
EX-10.4
from 8-K 13 pages Corporate Executive Confidentiality, Non-Competition and Non-Solicitation Agreement
12/34/56
EX-10.1
from 8-K 4 pages Neither This Letter Nor Any Other Written or Oral Statement by the Company, Including Any Policy Manual or Handbook, Creates a Contract of Employment, Express or Implied, or a Guarantee of Employment for Any Specific Time Period. at All Times, Your Employment Will Be at Will, Meaning Either You or Zimmer Biomet May Terminate Your Employment for Any Reasons and at Any Time, With or Without Notice. Annual Merit Adjustment Beginning in 2023, You Will Be Eligible for Zimmer Biomet’s Annual Merit Review Process Which Involves Possible Base Pay Adjustments Consistent With Your Job Performance. Your First Merit Adjustment May Be Pro-Rated, Depending on Your Hire Date. Executive Performance Incentive Plan
12/34/56
EX-10.4
from 10-Q 3 pages The Borrower and the Bank Wish to Amend the Agreement in Certain Respects
12/34/56
EX-10.3
from 10-Q 3 pages The Borrower and the Bank Wish to Amend the Agreement in Certain Respects
12/34/56
EX-10.2
from 10-Q 21 pages Zimmer Biomet Deferred Compensation Plan
12/34/56
EX-10.1
from 10-Q 1 page Amendment to the Zimmer Biomet Holdings, Inc. Executive Severance Plan
12/34/56
EX-10.10
from 8-K 9 pages Material contract
12/34/56
EX-10.9
from 8-K 9 pages Material contract
12/34/56
EX-10.8
from 8-K 17 pages Transitional Trademark License Agreement
12/34/56
EX-10.7
from 8-K 42 pages Reverse Transition Manufacturing and Supply Agreement Dated as of March 1, 2022 by and Between Zimvie Inc. and Zimmer, Inc
12/34/56
EX-10.6
from 8-K 45 pages Transition Manufacturing and Supply Agreement Dated as of March 1, 2022 by and Between Zimmer, Inc. and Zimvie Inc
12/34/56